Recent advances in managing/understanding meningioma

F1000Research
Nawal ShaikhJ J Raizer

Abstract

Meningiomas are the most common adult primary intracranial tumor. Despite their higher incidence, there have not-until recently-been as many advances in understanding and managing meningiomas. Thus far, two broad classes of meningiomas have emerged on the basis of their mutational profile: those driven by neurofibromatosis 2 (NF2) inactivation and those with non-NF2 driver gene alterations, such as mammalian target of rapamycin and Hedgehog, Wingless/b-catenin, Notch, transforming growth factor-b receptor, mitogen-activated protein kinase, and phospholipase C pathway alterations. In addition to improvements in molecular diagnostics, advances in imaging are being studied to better predict tumor behavior, stratify risk, and potentially monitor for disease response. Management consists primarily of surgery and radiation therapy and there has been limited success from medical therapies, although novel targeted agents are now in clinical trials. Advances in imaging and understanding of the genetic makeup of meningiomas demonstrate the huge potential in revolutionizing the classification, diagnosis, management, and prognosis of meningiomas..

References

Apr 1, 1990·International Journal of Radiation Oncology, Biology, Physics·J GlaholmJ H Crow
Mar 5, 1998·Journal of Neuroscience Research·H M Xu, D H Gutmann
Feb 3, 2000·International Journal of Radiation Oncology, Biology, Physics·L K GoyalG H Barnett
Feb 13, 2001·British Journal of Cancer·U SchmitzA von Deimling
Jul 24, 2002·Journal of Neurosurgery·John Y K LeeL Dade Lunsford
Feb 28, 2003·International Journal of Radiation Oncology, Biology, Physics·Bruce E PollockShawn A Schreiner
Jun 26, 2003·Neurosurgery·Makoto NakamuraMadjid Samii
Feb 1, 1957·Journal of Neurology, Neurosurgery, and Psychiatry·D SIMPSON
Sep 20, 2005·Journal of Neurology, Neurosurgery, and Psychiatry·W KreilG Papaefthymiou
Jan 10, 2006·Neurosurgical Focus·Brian T Ragel, Randy L Jensen
Sep 6, 2007·Neurology·Marc C ChamberlainCamilo E Fadul
Feb 28, 2008·Neurosurgery·Douglas KondziolkaJohn C Flickinger
Oct 28, 2008·Neoplasia : an International Journal for Oncology Research·Katherine StriedingerAnita Lal
Nov 4, 2008·Journal of Neurosurgery·Yoshiyasu IwaiHidetoshi Ikeda
Jun 30, 2009·Journal of Neuro-oncology·Anne DurandJacques Guyotat
Sep 3, 2010·Journal of Neuro-oncology·Christian Mawrin, Arie Perry
Apr 16, 2011·Journal of Korean Neurosurgical Society·Byung-Won KimOh-Lyong Kim
Oct 1, 2013·Journal of Neurosurgery·Shunya HanakitaNobuhito Saito
Dec 24, 2013·The Neuroscientist : a Review Journal Bringing Neurobiology, Neurology and Psychiatry·Antonio Di IevaMiguel Martín-Landrove
Jun 27, 2014·Journal of Neuro-oncology·Yunseon ChoiJung-Il Lee
Oct 8, 2014·Journal of Neuropathology and Experimental Neurology·Ronald KoschnyTom M Ganten
Mar 19, 2015·Biochemical and Biophysical Research Communications·Maomao WangChong Liang
Apr 15, 2015·Seminars in Cancer Biology·Paul YaswenXujuan Yang
May 6, 2015·International Journal of Molecular Sciences·Mustafa El-KhatibJan Frédérick Cornelius
Jan 16, 2016·Journal of Neurosurgery·Wenya Linda BiIan F Dunn
Jan 18, 2016·Journal of Clinical Neuroscience : Official Journal of the Neurosurgical Society of Australasia·Michael D JenkinsonMohsen Javadpour
Jan 19, 2016·Clinical Neurology and Neurosurgery·Mathew J GallagherEmmanuel Chavredakis
Feb 13, 2016·Neuro-oncology·Michael SommerauerFelix P Kuhn
Mar 26, 2016·Neurosurgery Clinics of North America·Or Cohen-InbarJason P Sheehan

❮ Previous
Next ❯

Citations

Sep 29, 2019·Current Treatment Options in Neurology·Michele BailoPietro Mortini
Nov 2, 2019·Cancers·Antonio CarettaCarla Mucignat-Caretta
Jan 24, 2020·Frontiers in Oncology·May Al-RashedMalak Abedalthagafi
Jun 27, 2020·Scientific Reports·Janaína M SilvaJuliana de S da G Fischer
Apr 25, 2020·International Journal of Molecular Sciences·Maria L Perepechaeva, Alevtina Y Grishanova
Sep 26, 2020·Frontiers in Oncology·Lianhua ZhaoZaiyu Guo
Jul 23, 2020·Reviews in the Neurosciences·Lei WangZhengwen He
Mar 16, 2021·Mayo Clinic Proceedings. Innovations, Quality & Outcomes·Anza ZahidSani H Kizilbash
May 16, 2021·Pathology, Research and Practice·Débora SallesJoão N Stávale
Oct 6, 2021·Der Hautarzt; Zeitschrift für Dermatologie, Venerologie, und verwandte Gebiete·Julia WermeltManoj Mannil

❮ Previous
Next ❯

Methods Mentioned

BETA
imaging techniques
surgical resection

Clinical Trials Mentioned

NCT00895622
NCT03180268
NCT01125046
NCT02333565
NCT02234050
NCT01892397
NCT02847559
NCT02523014

Related Concepts

Related Feeds

Adherens Junctions

An adherens junction is defined as a cell junction whose cytoplasmic face is linked to the actin cytoskeleton. They can appear as bands encircling the cell (zonula adherens) or as spots of attachment to the extracellular matrix (adhesion plaques). Adherens junctions uniquely disassemble in uterine epithelial cells to allow the blastocyst to penetrate between epithelial cells. Discover the latest research on adherens junctions here.

Cadherins and Catenins

Cadherins (named for "calcium-dependent adhesion") are a type of cell adhesion molecule (CAM) that is important in the formation of adherens junctions to bind cells with each other. Catenins are a family of proteins found in complexes with cadherin cell adhesion molecules of animal cells: alpha-catenin can bind to β-catenin and can also bind actin. β-catenin binds the cytoplasmic domain of some cadherins. Discover the latest research on cadherins and catenins here.

Related Papers

Journal of the Indian Medical Association
J GurunathanD Kailairajan
Acta neurochirurgica
Gokcen GokceHalil Ibrahim Altinsoy
Otolaryngologic Clinics of North America
Michael Hoa, William H Slattery
© 2022 Meta ULC. All rights reserved